Takeda takes on Sanofi with new global dengue vaccine data

(Reuters) - Takeda Pharmaceutical's experimental dengue vaccine has produced promising long-term results in clinical tests, boosting the Japanese company's global hopes for a product that will take on Sanofi's Dengvaxia.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news